Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models-Reference-Cited by-同舟云学术

Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models

Published:2015-05-21 Issue:21 Volume:125 Page:3326-3334
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Pickens Brandy¹,Mao Yingying¹,Li Dengju¹,Siegel Don L.¹,Poncz Mortimer²,Cines Douglas B.¹,Zheng X. Long¹³^ORCID

Affiliation:

1. Department of Pathology and Department of Laboratory Medicine, The University of Pennsylvania, Philadelphia, PA;

2. Division of Hematology, The Children’s Hospital of Philadelphia, Philadelphia, PA; and

3. Division of Laboratory Medicine, Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL

Abstract

Key Points Platelet-delivered ADAMTS13 inhibits arterial thrombosis after vascular injury. Platelet-delivered ADAMTS13 also prevents thrombotic thrombocytopenic purpura.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/125/21/3326/1386010/3326.pdf

Reference48 articles.

1. Localization of ADAMTS13 to the stellate cells of human liver.;Uemura;Blood,2005

2. Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage.;Turner;Blood,2009

3. Apical sorting of ADAMTS13 in vascular endothelial cells and Madin-Darby canine kidney cells depends on the CUB domains and their association with lipid rafts.;Shang;Blood,2006

4. Platelet-derived VWF-cleaving metalloprotease ADAMTS-13.;Liu;J Thromb Haemost,2005

5. Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets.;Suzuki;Biochem Biophys Res Commun,2004

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Packaging of supplemented urokinase into alpha granules of in vitro–grown megakaryocytes for targeted nascent clot lysis;Blood Advances;2024-07-12

2. Targeting neutrophil extracellular trap accumulation under flow in patients with immune-mediated thrombotic thrombocytopenic purpura;Blood Advances;2024-05-21

3. Packaging of supplemented urokinase into naked alpha-granules ofin vitro-grown megakaryocytes for targeted therapeutic delivery;2023-12-05

4. Targeted ADAMTS-13 replacement therapy for thrombotic thrombocytopenic purpura;Journal of Thrombosis and Haemostasis;2023-12

5. Immune thrombotic thrombocytopenic purpura: pathogenesis and novel therapies: a narrative review;Annals of Blood;2023-09